March 2019 FDA Recall Drug by Apotex Inc.
D-0992-2019 - Contraceptive Tablets Out of Sequence

This Class II drug recall was voluntarily initiated by Apotex Inc. on March 1, 2019 for the product Drug. The FDA reported the reason for recall as contraceptive tablets out of sequence. The product was distributed Nationwide and the recall is currently completed.

Recall Number: D-0992-2019

Reason for Recall
Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement.
Initiated
03-01-2019
Reported
03-13-2019
Quantity
82,705 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA.
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.03 mg, 28 Tablets Blister, 1 Unit (NDC 60505-4183-1) packaged as 84 Tablets Blister, 3x1 Unit per carton (NDC 60505-4183-3), Rx Only, Manufactured for: Apotex Corp., Weston, FL 33326; Manufactured by: Oman Pharmaceutical Products Co. L.L.C., P.O. Box 1885, Postal Code 111, Seeb.

Batch or Lot Expiration Information

Lot# Lots: 7DY008A, 7DY009A, 7DY010A, 7DY011A, Exp. 08/2020